THORACIC TUMORS
Clinical trials for THORACIC TUMORS explained in plain language.
Never miss a new study
Get alerted when new THORACIC TUMORS trials appear
Sign up with your email to follow new studies for THORACIC TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets rare lung tumor gene defect
Disease control OngoingThis early-stage trial is testing a new drug called anvumetostat, alone or with other cancer drugs, in about 49 adults with advanced lung or chest tumors that lack a gene called MTAP. The main goals are to find the safest dose and to see what side effects occur. Researchers will …
Matched conditions: THORACIC TUMORS
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Ultrasound-Guided epidurals: a missed opportunity?
Knowledge-focused TerminatedThis study aimed to see if using real-time ultrasound during a thoracic epidural block makes the procedure more reliable. It was designed for adults with chest or abdominal pain or rib fractures. The study was withdrawn before enrolling any participants, so no results are availab…
Matched conditions: THORACIC TUMORS
Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC